Admon A - Search Results

1

UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.

Wolf Y, Bartok O, Patkar S, Eli GB, Cohen S, Litchfield K, Levy R, Jiménez-Sánchez A, Trabish S, Lee JS, Karathia H, Barnea E, Day CP, Cinnamon E, Stein I, Solomon A, Bitton L, Pérez-Guijarro E, Dubovik T, Shen-Orr SS, Miller ML, Merlino G, Levin Y, Pikarsky E, Eisenbach L, Admon A, Swanton C, Ruppin E, Samuels Y. Wolf Y, et al. Among authors: admon a. Cell. 2019 Sep 19;179(1):219-235.e21. doi: 10.1016/j.cell.2019.08.032. Epub 2019 Sep 12. Cell. 2019. PMID: 31522890 Free PMC article.

2

Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens.

Barnea E, Beer I, Patoka R, Ziv T, Kessler O, Tzehoval E, Eisenbach L, Zavazava N, Admon A. Barnea E, et al. Among authors: admon a. Eur J Immunol. 2002 Jan;32(1):213-22. doi: 10.1002/1521-4141(200201)32:1<213::AID-IMMU213>3.0.CO;2-8. Eur J Immunol. 2002. PMID: 11782012 Free article.

3

Large-scale analysis of HLA peptides presented by HLA-Cw4.

Buchsbaum S, Barnea E, Dassau L, Beer I, Milner E, Admon A. Buchsbaum S, et al. Among authors: admon a. Immunogenetics. 2003 Jun;55(3):172-176. doi: 10.1007/s00251-003-0570-0. Epub 2003 May 16. Immunogenetics. 2003. PMID: 12750860

4

Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.

Admon A, Barnea E, Ziv T. Admon A, et al. Mol Cell Proteomics. 2003 Jun;2(6):388-98. doi: 10.1074/mcp.R300004-MCP200. Epub 2003 Jun 23. Mol Cell Proteomics. 2003. PMID: 12821722 Free article. Review.

5

Improving large-scale proteomics by clustering of mass spectrometry data.

Beer I, Barnea E, Ziv T, Admon A. Beer I, et al. Among authors: admon a. Proteomics. 2004 Apr;4(4):950-60. doi: 10.1002/pmic.200300652. Proteomics. 2004. PMID: 15048977

6

A novel DNA methyltransferase I-derived peptide eluted from soluble HLA-A*0201 induces peptide-specific, tumor-directed cytotoxic T cells.

Berg M, Barnea E, Admon A, Zavazava N. Berg M, et al. Among authors: admon a. Int J Cancer. 2004 Nov 10;112(3):426-32. doi: 10.1002/ijc.20381. Int J Cancer. 2004. PMID: 15382068 Free article.

7

Evaluation of prefractionation methods as a preparatory step for multidimensional based chromatography of serum proteins.

Barnea E, Sorkin R, Ziv T, Beer I, Admon A. Barnea E, et al. Among authors: admon a. Proteomics. 2005 Aug;5(13):3367-75. doi: 10.1002/pmic.200401221. Proteomics. 2005. PMID: 16047308

8

Centralized data analysis of a large interlaboratory proteomics project: a feasibility study.

Beer I, Barnea E, Admon A. Beer I, et al. Among authors: admon a. Proteomics. 2005 Aug;5(13):3491-6. doi: 10.1002/pmic.200401336. Proteomics. 2005. PMID: 16052626

9

The turnover kinetics of major histocompatibility complex peptides of human cancer cells.

Milner E, Barnea E, Beer I, Admon A. Milner E, et al. Among authors: admon a. Mol Cell Proteomics. 2006 Feb;5(2):357-65. doi: 10.1074/mcp.M500241-MCP200. Epub 2005 Nov 4. Mol Cell Proteomics. 2006. PMID: 16272561 Free article.

10

Comparative proteomics of small cell lung carcinoma.

Ziv T, Barnea E, Segal H, Sharon R, Beer I, Admon A. Ziv T, et al. Among authors: admon a. Cancer Biomark. 2006;2(6):219-34. doi: 10.3233/cbm-2006-2601. Cancer Biomark. 2006. PMID: 17264394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page